 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
Liver Cancer
| AFP Scan |
Scan detection for liver cancer |
Immunomedics |
II |
| BAY 43-9006 (sorafenib) |
MKI VEGFR-2, VEGFR-3, PDGFR-B, RAF, Kit, FLT-3, RET |
Bayer Pharmaceuticals Onyx Pharmaceuticals |
II |
| DENSP ( diethylnorsperime) |
Oolyamine analog |
Genzyme |
I |
| DTI-015 |
Carmustine in ethanol solvent |
Direct Therapeutics |
I |
| bHAFP-Y-90 |
Radiolabelled monoclonal antibody |
Immunomedics |
I |
| Immu-105 |
MoAb |
Immunomedics |
I |
| Megestrol |
Progesterone |
Bristol-Myers Squibb |
III |
| MTC-DOX |
Anthracycline |
FeRx |
II |
| Oncolytic HSV |
Genetically engineered HSV |
Medigene |
II |
| Sanvar SR (vapreotide) |
Somastain analog |
H# Pharma Inc |
II |
| T138067 |
Microtubular inhibitor |
Tularik |
II/III |
| T607 |
Tubulin antagonist |
Tularik, Amgen |
II |
| T67 |
Tubulin antagonist |
Tularik |
III |
| Thymitaq (nolatrexed) |
Thymidylate synthase inhibitor |
Eximias Pharmaceutical |
III |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
 View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|
Patient Home
Meeting Calendar
